Epic™
Vascular Self-Expanding Stent System
Ideal for the Iliac: The Epic Stent is a self-expanding Nitinol stent designed to sustain vessel patency, while providing enhanced visibility and accuracy during placement.
Key Resources
Explore
Product Details
Epic Stent System provides exactly the right balance
Exceptional Flexibility
|
Balanced Radial Force
|
Excellent Deployment Accuracy
|
Fracture Resistance
|
Product Specifications
Stent Diameters | 6 to 12 mm |
Stent Lengths | 20, 30, 40, 60, 80, 100, 120 mm |
Catheter Lengths | 75, 120 cm |
Guide Wire System | 0.035" OTW |
Introducer Sheath Compatibility | 6 F across all sizes |
Catheter Nominal O.D. | 0.079" to 0.077" (distal to proximal) |
Epic Stent Size Matrix
6 F Compatibility Across All Sizes | ||||||||
Length (mm) | ||||||||
Diameter (mm) | ||||||||
20 | 30 | 40 | 60 | 80 | 100 | 120 | ||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
10 | ||||||||
12 | ||||||||
Catheter lengths: 75 cm, 120 cm Guidewire system: 0.035" OTW |
C-Code
The C-code used for this product is C1876, Stent, non-coated/non-covered with delivery system. C-codes are used for hospital outpatient device reporting for Medicare and some private payers.
Note: Boston Scientific is not responsible for the correct use of codes on submitted claims; this information does not constitute reimbursement or legal advice.
ORION Clinical Information
• 0 amputations at 3 years (106 subjects) • 89.9% Freedom from TLR at 3 years (143 lesions) |
ORION US IDE Clinical Trial to demonstrate similar patency across all TASC classifications |
12-month Primary Patency by TASC Classification
12-month data
- 0% MI at 30 days (0/111)
- 3.4% MAE at 9-months (4/117)
- 0% MI in-hospital (0/111)
- 5.4% TVR at 12-months (6/111)
- 0% Amputation of index limb at 12-months (0/111)
Composite Success Rates
- 100% Technical Success
(Per lesion) (166/166)
- 99.2% Procedural Success
(Per subject) (124/125)
- 95.3% Late Clinical Success at 12 months
- (Per subject) (101/106)